Not Yet Recruiting PHASE1 INTERVENTIONAL 4-arm
NCT07386730
A Study of Psychedelics in Healthy Older Adults With Low Well-being (OAD1)
A Double Blind, Randomized Trial Investigating the Safety, Feasibility, and Mechanisms of Psychedelics in Healthy Older Adults With Low Well-being as Moderated by Biomarkers for Preclinical Alzheimer's Disease
Sponsor: Jennifer Mitchell
Interventions
Dextromethorphan (DXM) Psilocybin (drug)
Updated 1 time since 2026 Last updated: Jan 29, 2026 Started: Mar 31, 2026 Primary completion: Feb 28, 2030 Completion: Feb 28, 2030
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE1 clinical study on Anhedonia in Healthy Volunteers and Older Adults (50-90 Years), this trial is actively recruiting participants. The trial is conducted by Jennifer Mitchell and has accumulated 1 data snapshot since 2026. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Not Yet Recruiting — PHASE1
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Jennifer Mitchell
Data source: University of California, San Francisco
For direct contact, visit the study record on ClinicalTrials.gov .